The Market Reports

Index

1 Daptomycin API Market Overview
1.1 Product Overview and Scope of Daptomycin API
1.2 Daptomycin API Segment by Type
1.2.1 Global Daptomycin API Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 99%
1.2.3 98%
1.2.4 Others
1.3 Daptomycin API Segment by Application
1.3.1 Global Daptomycin API Sales Comparison by Application: (2021-2027)
1.3.2 350mg/vial
1.3.3 500mg/vial
1.3.4 Others
1.4 Global Daptomycin API Market Size Estimates and Forecasts
1.4.1 Global Daptomycin API Revenue 2016-2027
1.4.2 Global Daptomycin API Sales 2016-2027
1.4.3 Daptomycin API Market Size by Region: 2016 Versus 2021 Versus 2027

2 Daptomycin API Market Competition by Manufacturers
2.1 Global Daptomycin API Sales Market Share by Manufacturers (2016-2021)
2.2 Global Daptomycin API Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Daptomycin API Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Daptomycin API Manufacturing Sites, Area Served, Product Type
2.5 Daptomycin API Market Competitive Situation and Trends
2.5.1 Daptomycin API Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Daptomycin API Players Market Share by Revenue
2.5.3 Global Daptomycin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Daptomycin API Retrospective Market Scenario by Region
3.1 Global Daptomycin API Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Daptomycin API Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Daptomycin API Market Facts & Figures by Country
3.3.1 North America Daptomycin API Sales by Country
3.3.2 North America Daptomycin API Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Daptomycin API Market Facts & Figures by Country
3.4.1 Europe Daptomycin API Sales by Country
3.4.2 Europe Daptomycin API Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Daptomycin API Market Facts & Figures by Region
3.5.1 Asia Pacific Daptomycin API Sales by Region
3.5.2 Asia Pacific Daptomycin API Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Daptomycin API Market Facts & Figures by Country
3.6.1 Latin America Daptomycin API Sales by Country
3.6.2 Latin America Daptomycin API Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Daptomycin API Market Facts & Figures by Country
3.7.1 Middle East and Africa Daptomycin API Sales by Country
3.7.2 Middle East and Africa Daptomycin API Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Daptomycin API Historic Market Analysis by Type
4.1 Global Daptomycin API Sales Market Share by Type (2016-2021)
4.2 Global Daptomycin API Revenue Market Share by Type (2016-2021)
4.3 Global Daptomycin API Price by Type (2016-2021)

5 Global Daptomycin API Historic Market Analysis by Application
5.1 Global Daptomycin API Sales Market Share by Application (2016-2021)
5.2 Global Daptomycin API Revenue Market Share by Application (2016-2021)
5.3 Global Daptomycin API Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Xellia Pharmaceuticals
6.1.1 Xellia Pharmaceuticals Corporation Information
6.1.2 Xellia Pharmaceuticals Description and Business Overview
6.1.3 Xellia Pharmaceuticals Daptomycin API Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Xellia Pharmaceuticals Daptomycin API Product Portfolio
6.1.5 Xellia Pharmaceuticals Recent Developments/Updates
6.2 Rochem International Inc
6.2.1 Rochem International Inc Corporation Information
6.2.2 Rochem International Inc Description and Business Overview
6.2.3 Rochem International Inc Daptomycin API Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Rochem International Inc Daptomycin API Product Portfolio
6.2.5 Rochem International Inc Recent Developments/Updates
6.3 Tecoland Corporation
6.3.1 Tecoland Corporation Corporation Information
6.3.2 Tecoland Corporation Description and Business Overview
6.3.3 Tecoland Corporation Daptomycin API Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Tecoland Corporation Daptomycin API Product Portfolio
6.3.5 Tecoland Corporation Recent Developments/Updates
6.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co
6.4.1 Livzon Group Fuzhou Fuxing Pharmaceutical Co Corporation Information
6.4.2 Livzon Group Fuzhou Fuxing Pharmaceutical Co Description and Business Overview
6.4.3 Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Product Portfolio
6.4.5 Livzon Group Fuzhou Fuxing Pharmaceutical Co Recent Developments/Updates
6.5 Chongqing DaXin Pharmaceutical Co
6.5.1 Chongqing DaXin Pharmaceutical Co Corporation Information
6.5.2 Chongqing DaXin Pharmaceutical Co Description and Business Overview
6.5.3 Chongqing DaXin Pharmaceutical Co Daptomycin API Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Chongqing DaXin Pharmaceutical Co Daptomycin API Product Portfolio
6.5.5 Chongqing DaXin Pharmaceutical Co Recent Developments/Updates
6.6 Suzhou Pharmaceutical Technology Co
6.6.1 Suzhou Pharmaceutical Technology Co Corporation Information
6.6.2 Suzhou Pharmaceutical Technology Co Description and Business Overview
6.6.3 Suzhou Pharmaceutical Technology Co Daptomycin API Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Suzhou Pharmaceutical Technology Co Daptomycin API Product Portfolio
6.6.5 Suzhou Pharmaceutical Technology Co Recent Developments/Updates
6.7 Huazhong Pharmaceutical Co
6.6.1 Huazhong Pharmaceutical Co Corporation Information
6.6.2 Huazhong Pharmaceutical Co Description and Business Overview
6.6.3 Huazhong Pharmaceutical Co Daptomycin API Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Huazhong Pharmaceutical Co Daptomycin API Product Portfolio
6.7.5 Huazhong Pharmaceutical Co Recent Developments/Updates
6.8 Athos
6.8.1 Athos Corporation Information
6.8.2 Athos Description and Business Overview
6.8.3 Athos Daptomycin API Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Athos Daptomycin API Product Portfolio
6.8.5 Athos Recent Developments/Updates

7 Daptomycin API Manufacturing Cost Analysis
7.1 Daptomycin API Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Daptomycin API
7.4 Daptomycin API Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Daptomycin API Distributors List
8.3 Daptomycin API Customers

9 Daptomycin API Market Dynamics
9.1 Daptomycin API Industry Trends
9.2 Daptomycin API Growth Drivers
9.3 Daptomycin API Market Challenges
9.4 Daptomycin API Market Restraints

10 Global Market Forecast
10.1 Daptomycin API Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Daptomycin API by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Daptomycin API by Type (2022-2027)
10.2 Daptomycin API Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Daptomycin API by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Daptomycin API by Application (2022-2027)
10.3 Daptomycin API Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Daptomycin API by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Daptomycin API by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Daptomycin API Sales (MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Daptomycin API Sales (MT) Comparison by Application (2021-2027)
Table 3. Global Daptomycin API Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Daptomycin API Covered in This Study
Table 5. Global Daptomycin API Sales (MT) of Key Manufacturers (2016-2021)
Table 6. Global Daptomycin API Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Daptomycin API Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Daptomycin API Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Daptomycin API Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Daptomycin API Manufacturing Sites and Area Served
Table 11. Manufacturers Daptomycin API Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Daptomycin API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Daptomycin API as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Daptomycin API Sales by Region (2016-2021) & (MT)
Table 16. Global Daptomycin API Sales Market Share by Region (2016-2021)
Table 17. Global Daptomycin API Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Daptomycin API Sales by Country (2016-2021) & (MT)
Table 19. North America Daptomycin API Sales Market Share by Country (2016-2021)
Table 20. North America Daptomycin API Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Daptomycin API Revenue Market Share by Country (2016-2021)
Table 22. Europe Daptomycin API Sales by Country (2016-2021) & (MT)
Table 23. Europe Daptomycin API Sales Market Share by Country (2016-2021)
Table 24. Europe Daptomycin API Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Daptomycin API Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Daptomycin API Sales by Region (2016-2021) & (MT)
Table 27. Asia Pacific Daptomycin API Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Daptomycin API Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Daptomycin API Revenue Market Share by Region (2016-2021)
Table 30. Latin America Daptomycin API Sales by Country (2016-2021) & (MT)
Table 31. Latin America Daptomycin API Sales Market Share by Country (2016-2021)
Table 32. Latin America Daptomycin API Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Daptomycin API Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Daptomycin API Sales by Country (2016-2021) & (MT)
Table 35. Middle East and Africa Daptomycin API Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Daptomycin API Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Daptomycin API Revenue Market Share by Country (2016-2021)
Table 38. Global Daptomycin API Sales (MT) by Type (2016-2021)
Table 39. Global Daptomycin API Sales Market Share by Type (2016-2021)
Table 40. Global Daptomycin API Revenue (Million US$) by Type (2016-2021)
Table 41. Global Daptomycin API Revenue Share by Type (2016-2021)
Table 42. Global Daptomycin API Price (USD/MT) by Type (2016-2021)
Table 43. Global Daptomycin API Sales (MT) by Application (2016-2021)
Table 44. Global Daptomycin API Sales Market Share by Application (2016-2021)
Table 45. Global Daptomycin API Revenue (Million US$) by Application (2016-2021)
Table 46. Global Daptomycin API Revenue Share by Application (2016-2021)
Table 47. Global Daptomycin API Price (USD/MT) by Application (2016-2021)
Table 48. Xellia Pharmaceuticals Corporation Information
Table 49. Xellia Pharmaceuticals Description and Business Overview
Table 50. Xellia Pharmaceuticals Daptomycin API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Xellia Pharmaceuticals Daptomycin API Product
Table 52. Xellia Pharmaceuticals Recent Developments/Updates
Table 53. Rochem International Inc Corporation Information
Table 54. Rochem International Inc Description and Business Overview
Table 55. Rochem International Inc Daptomycin API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Rochem International Inc Daptomycin API Product
Table 57. Rochem International Inc Recent Developments/Updates
Table 58. Tecoland Corporation Corporation Information
Table 59. Tecoland Corporation Description and Business Overview
Table 60. Tecoland Corporation Daptomycin API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Tecoland Corporation Daptomycin API Product
Table 62. Tecoland Corporation Recent Developments/Updates
Table 63. Livzon Group Fuzhou Fuxing Pharmaceutical Co Corporation Information
Table 64. Livzon Group Fuzhou Fuxing Pharmaceutical Co Description and Business Overview
Table 65. Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Product
Table 67. Livzon Group Fuzhou Fuxing Pharmaceutical Co Recent Developments/Updates
Table 68. Chongqing DaXin Pharmaceutical Co Corporation Information
Table 69. Chongqing DaXin Pharmaceutical Co Description and Business Overview
Table 70. Chongqing DaXin Pharmaceutical Co Daptomycin API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Chongqing DaXin Pharmaceutical Co Daptomycin API Product
Table 72. Chongqing DaXin Pharmaceutical Co Recent Developments/Updates
Table 73. Suzhou Pharmaceutical Technology Co Corporation Information
Table 74. Suzhou Pharmaceutical Technology Co Description and Business Overview
Table 75. Suzhou Pharmaceutical Technology Co Daptomycin API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Suzhou Pharmaceutical Technology Co Daptomycin API Product
Table 77. Suzhou Pharmaceutical Technology Co Recent Developments/Updates
Table 78. Huazhong Pharmaceutical Co Corporation Information
Table 79. Huazhong Pharmaceutical Co Description and Business Overview
Table 80. Huazhong Pharmaceutical Co Daptomycin API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Huazhong Pharmaceutical Co Daptomycin API Product
Table 82. Huazhong Pharmaceutical Co Recent Developments/Updates
Table 83. Athos Corporation Information
Table 84. Athos Description and Business Overview
Table 85. Athos Daptomycin API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Athos Daptomycin API Product
Table 87. Athos Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Daptomycin API Distributors List
Table 91. Daptomycin API Customers List
Table 92. Daptomycin API Market Trends
Table 93. Daptomycin API Growth Drivers
Table 94. Daptomycin API Market Challenges
Table 95. Daptomycin API Market Restraints
Table 96. Global Daptomycin API Sales Forecast by Type (2022-2027) & (MT)
Table 97. Global Daptomycin API Sales Market Share Forecast by Type (2022-2027)
Table 98. Global Daptomycin API Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 99. Global Daptomycin API Revenue Market Share Forecast by Type (2022-2027)
Table 100. Global Daptomycin API Sales Forecast by Application (2022-2027) & (MT)
Table 101. Global Daptomycin API Sales Market Share Forecast by Application (2022-2027)
Table 102. Global Daptomycin API Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 103. Global Daptomycin API Revenue Market Share Forecast by Application (2022-2027)
Table 104. Global Daptomycin API Sales Forecast by Region (2022-2027) & (MT)
Table 105. Global Daptomycin API Sales Market Share Forecast by Region (2022-2027)
Table 106. Global Daptomycin API Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 107. Global Daptomycin API Revenue Market Share Forecast by Region (2022-2027)
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Daptomycin API
Figure 2. Global Daptomycin API Market Share by Type in 2020 & 2027
Figure 3. 99% Product Picture
Figure 4. 98% Product Picture
Figure 5. Others Product Picture
Figure 6. Global Daptomycin API Market Share by Application in 2020 & 2027
Figure 7. 350mg/vial
Figure 8. 500mg/vial
Figure 9. Others
Figure 10. Global Daptomycin API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Daptomycin API Market Size 2016-2027 (US$ Million)
Figure 12. Global Daptomycin API Sales 2016-2027 (MT)
Figure 13. Global Daptomycin API Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Daptomycin API Sales Share by Manufacturers in 2020
Figure 15. Global Daptomycin API Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Daptomycin API Players: Market Share by Revenue in 2020
Figure 17. Daptomycin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Daptomycin API Sales Market Share by Region (2016-2021)
Figure 19. Global Daptomycin API Sales Market Share by Region in 2020
Figure 20. Global Daptomycin API Revenue Market Share by Region (2016-2021)
Figure 21. Global Daptomycin API Revenue Market Share by Region in 2020
Figure 22. United States Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Taiwan Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Daptomycin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Daptomycin API by Type (2016-2021)
Figure 45. Sales Market Share of Daptomycin API by Application (2016-2021)
Figure 46. Sales Market Share of Daptomycin API by Application in 2020
Figure 47. Revenue Share of Daptomycin API by Application (2016-2021)
Figure 48. Revenue Share of Daptomycin API by Application in 2020
Figure 49. Manufacturing Cost Structure of Daptomycin API
Figure 50. Manufacturing Process Analysis of Daptomycin API
Figure 51. Daptomycin API Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed